Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
NCT00268788
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Multifocal Motor Neuropathy
Interventions
DRUG:
Subcutaneous immunoglobulin
DRUG:
Intravenous immunoglobulin
Sponsor
University of Aarhus